Immunotherapy is one of the most promising new therapies for hepatocellular carcinoma (HCC) in recent years.In this study,folate-conjugated chitosan nanopar
Tumor microenvironment is characteristic of ischemia and starvation of nutrient.Glil is a strong positive transcriptional activator of the downstream of Hed